Concepedia

G. C. CRAWLEY

GC

9

Publications

314

Citations

9

H-Index

1970

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

East Cheshire NHS Trust

G. C. CRAWLEY is an author at AstraZeneca (United Kingdom) specializing in natural sciences, biochemistry, and pharmacology.

Top concepts

Publications per year

1970–2003

9

Publications

9

Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors

G. C. CRAWLEY, Robert I. Dowell, Philip N. Edwards et al. · Journal of Medicinal Chemistry · 1992 · 84 citations · Full text

, , +16

(Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity

Bird, G. C. CRAWLEY, Martin P. Edwards et al. · Journal of Medicinal Chemistry · 1991 · 52 citations · Full text

Pre‐clinical pharmacology of ICI D2138, a potent orally‐active non‐redox inhibitor of 5‐lipoxygenase

R. M. McMillan, K E Spruce, G. C. CRAWLEY et al. · British Journal of Pharmacology · 1992 · 45 citations · Full text

Microbial Modification of Mycophenolic Acid

D. F. Jones, R. H. Moore, G. C. CRAWLEY · Journal of the Chemical Society C Organic · 1970 · 35 citations

, , +15

Total synthesis of (±)-fluorocurarine, the racemate of a Calabash-curare alkaloid

G. C. CRAWLEY, John Harley-Mason · Journal of the Chemical Society D Chemical Communications · 1971 · 24 citations

, , +12

Rows per page

1–5 of 9